First, the phase 3 trial of Moderna’s norovirus vaccine had to endure a clinical hold. | First, the phase 3 trial of ...
Reports third quarter revenue of $1.0 billion, GAAP net loss of $ (0.2) billion and GAAP EPS of $ (0.51) Improves 2025 ...
Dynavax Technologies Corporation , a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, and Vaxart, Inc. , a clinical-stage biotechnology company developing ...
Everyday Health on MSN
How Bad Is It Really to Reuse a Plastic Water Bottle?
Reusing plastic bottles can pose health risks due to bacterial growth and chemical leaching. Discover safe alternatives and tips for minimizing environmental impact.
LAKE WALES, Fla. — The FDA proposed a change to a 60-year-old rule that it said will benefit Florida citrus farmers. The rule would change the required minimum amount of dissolved sugar in pasteurized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback